Latest News, reports & updates

New partnership to eliminate hepatitis C in London kicks off at City Hall

02.03.20: Today, charities, doctors, nurses, addictions specialists, peer support workers and public health leads from across London are coming together to kick off plans for a ‘Routemap to eliminating hepatitis C in London’. This will set the direction for London to become the first global city to eliminate hepatitis C, ahead of the World Health...

read more >>

2020 Conference Agenda

read more >>

New report builds on evidence for expanding hepatitis C testing, and offering hepatitis C treatment, in pharmacies

The report’s findings build on ‘phase 1’ of the pilot and follows NHS England’s announcement in July that they will invest £4 million over the next 2 years in rolling out hepatitis C testing in selected pharmacies across the country. Hepatitis C is a blood borne virus that affects the liver and is transmitted by...

read more >>

New report calls for organisations involved with hepatitis C testing, treatment and care to improve data sharing

The new report, ‘Joining the Dots: Linking pathways to hepatitis C diagnosis and treatment’, highlights that, with people being diagnosed with hepatitis C at various different locations such as at a drugs service, prison, GP practice, or outreach service, it is crucial these organisations have systems that can process and share patient information efficiently. Effective...

read more >>

£4 million pledged to testing for hepatitis C in community pharmacies

The announcement came this week with the publication of The Community Pharmacy Contractual Framework for 2019/20 to 2023/24 by the Department of Health and Social Care, NHS England, NHS Improvement, and the Pharmaceutical Services Negotiating Committee. The Framework sets out that over 2019/20 and 2020/21, £2 million will be invested each year to support hepatitis...

read more >>

LJWG pilot celebrated as best practice by EMCDDA

The EMCDDA is an EU agency existing to provide the EU’s Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. In advance of World Hepatitis Day, the organisation published ‘Hepatitis C: new models of care for drugs services’. This report aims to highlight the...

read more >>

Mayor joins charities and doctors to spread the World Hepatitis Day ‘Get tested for hepatitis C’ message

Hepatitis C is a blood-borne virus, which primarily affects the liver. People can live with hepatitis C for decades without symptoms but untreated cases can cause fatal cirrhosis and liver cancer. Public Health England estimate there are 14,200 people living with hepatitis C in London and 113,000 people with the virus in England, around half...

read more >>

A call to action: Overcoming barriers to allow treatment in community pharmacies (July 2019)

Fully embracing the strategic priorities and ambitions to eliminate hepatitis C as a public health threat by 2025, the London Joint Working Group have been exploring the options around the introduction of a community pharmacy hepatitis C treatment service. Despite full local system support for the initiative and examples of similar services being introduced successfully...

read more >>

Minister urged to let pharmacies dispense hepatitis C treatments

Following the success of the LJWG’s hepatitis C pharmacy testing pilot, the group has joined forces with the All-Party Parliamentary Group on Liver Health to urge the government to allow pharmacies to dispense hepatitis C treatments. Chemist + Druggist magazine has reported on the issue, highlighting the LJWG pilot’s findings that 84% of people who...

read more >>

LJWG shortlisted for C+D awards for innovative hepatitis C pharmacy testing pilot

Working closely with 8 pharmacies across London, our hepatitis C pharmacy testing project offered point-of-care tests to people who use needle exchange services, engaging with and meeting the unmet needs of this vulnerable and high-risk group. The project developed a working model of testing and referral into treatment that is now being rolled out in...

read more >>